These sessions provide open discussion between recognized experts and session attendees, with an opportunity for attendees to interact personally with the experts.
MTP Sessions are not included with Registration, the fee for attendance is $40.00 USD per session. Please sign up to attend these sessions at the time of registration. If you have already registered and would like to add a session, please contact wclc2009-registration@meet-ics.com.
SATURDAY, AUGUST 1 (07:00 - 08:00)
| Medical Oncology | |
| MTP1 | Lung Cancer Vaccines – Glen Goss, Canada |
| MTP2 | Novel Therapies Improving Toxicities and Side Effects in Thoracic Radiation – Umberto Ricardi, Italy |
| Pulmonary | |
| MTP3 | Interventional Bronchoscopic Techniques in The Treatment of Lung Cancer - Thomas Sutedja, Netherlands |
| Biology | |
| MTP4 | Molecular Pathogenesis of Lung Cancer and its Precursor Lesions - Adi Gazdar, USA |
| MTP5 | Oncopolitics - James Mulshine, USA |
| Pathology | |
| MTP6 | Large Cell Carcinoma - Keith Kerr, UK |
| Surgery | |
| MTP7 | Maximizing Perioperative Outcome after Neoadjuvant Therapy - Stephen Swisher, USA |
| Supportive Care | |
| Radiation Oncology | |
| MTP9 | Thoracic Radiotherapy in SCLC - Andrew Turrisi, USA |
| Imaging | |
| MTP10 | After pemetrexed and cisplatin, what is the way forward? - Nicholas Vogelzang, USA |
SUNDAY, AUGUST 2 (07:00 - 08:00)
| Medical Oncology | |
| MTP11 | Bevacizumab Dosing and Duration - Christian Manegold, Germany |
| MTP12 | Novel Cytotoxics in Small Cell – Vera Hirsh, Canada |
| MTP13 | Systemic Treatment of Brain Metastasis in Lung Cancer - Corey Langer, USA |
| Pulmonary | |
| MTP14 | Management of Malignant Pleural Effusions - Philippe Astoul, France |
| Pathology | |
| MTP15 | Mesothelioma - Kirk Jones, USA |
| Biology | |
| MTP16 | Novel Signal Transduction Pathways - Giuseppe Giaccone, USA |
| MTP17 | Molecular Biology and Pathology of Lung Adenocarcinomas - Yasushi Yatabe, Japan |
| Radiation Oncology | |
| MTP18 | Management of Oligometastasis: Should Patients with Limited Sites of Metastasis be Treated Aggressively? - Andrea Bezjak, Canada |
| MTP19 | Current Status of Prophylactic Cranial Irradiation in SCLC - Cecile Le Pechoux, France |
| Mesothelioma | |
| MTP20 | Translational Research and Mesothelioma - Harvey Pass, USA |
| Supportive Care | |
| MTP21 | Neurological Complications of Lung Cancer and its Treatment - Jerome Posner, USA |
MONDAY, AUGUST 3 (07:00 - 08:00)
| Medical Oncology | |
| MTP22 | Management of Thymoma – Tracey Evans, USA |
| MTP23 | Special Populations: Elderly: Cesare Gridelli, Italy and PS2: - Rogerio Lilenbaum, USA |
| Pulmonary | |
| MTP24 | Evaluation of Solitary Pulmonary Nodules - David Midthun, USA |
| MTP25 | Bronchial Intraepithelial Neoplasia and Early Central Airway Lung Cancer: Screening,Diagnosis and Treatment.- Rex Yung, USA |
| Biology | |
| MTP26 | Gene-Directed Therapy in Lung Cancer - Jack Roth, USA |
| Mesothelioma | |
| MTP27 | The Extended Debate on Surgery |
| Chair: Valerie Rusch, USA | |
|
|
| Pathology | |
| MTP28 | Preneoplastic Lesions - Andrew Nicholson, UK |
| Supportive Care | |
| MTP29 | Comprehensive Supportive Care in the Patient with Mesothelioma - Helen Clayson, UK |
| Radiation Oncology/Surgery | |
| MTP30 | Radiotherapy for Malignant Pleural Mesothelioma: - Allan Price, Thymic Tumors: Where is the Evidence? - Robert Cameron, USA |
| Imaging | |
| MTP31 | Image Guidance in Judging Therapeutic Response - David Shelton, USA |
TUESDAY, AUGUST 4 (07:00 - 08:00)
| Medical Oncology | |
| MTP32 | Ethnic Differences in Chemotherapy Toxicities and Outcomes - Alex Yuang-Chi Chang, Singapore |
| MTP33 | Mechanisms of Drug Resistance to Targeted Agents -Pasi Janne, USA |
| MTP34 | Limited Surgical Resection and Local Radiation Therapy for High Risk NSCLC - Jeffrey Bogart, USA |
| MTP35 | Ethnic Considerations in EGFR Biology and Clinical Parameters - Keunchil Park, South Korea |
| Surgery | |
| MTP36 | Emerging Endoscopic Staging Techniques - Todd Demmy, USA |
| Radiation Oncology | |
| MTP37 | Proton Beam Radiotherapy - James Cox, USA |
| Pulmonary | |
| MTP38 | Physiologic Evaluation of Patients with Lung Cancer for Lung Resection - David Cooke, USA |
| Biology | |
| MTP39 | Clinical Implications of the New Staging System: Pulmonary Perspective and Oncology Perspective - Pieter Postmus, Netherlands (Pulmonary); Sarita Dubey, USA (Oncology) |
| Pathology | |
| MTP40 | Mediastinal Tumors - Cesar Moran, USA |
| MTP41 | Should Treatment of NSCLC be Histology-Based? - Lawrence Einhorn, USA |
